Medications That Cause Neutropenia
Numerous medications can cause neutropenia through various mechanisms, with the most common culprits being chemotherapy agents (tyrosine kinase inhibitors like imatinib, dasatinib, nilotinib), antibiotics (sulfamethoxazole-trimethoprim, β-lactams, vancomycin, quinolones), antipsychotics (clozapine), immunosuppressants (rituximab), NSAIDs, antithyroid drugs (propylthiouracil), and anticonvulsants (carbamazepine).
Chemotherapy and Targeted Agents
The tyrosine kinase inhibitors used in chronic myeloid leukemia are well-documented causes of grade 3-4 neutropenia (ANC < 1000/mm³):
- Imatinib: Hold when ANC < 1000/mm³ until recovery to ≥ 1500/mm³, then resume at starting dose; if recurrent, reduce to 300 mg 1, 2
- Nilotinib: Hold when ANC < 1000/mm³ until recovery, resume at prior dose if within 2 weeks, otherwise reduce to 400 mg daily 3, 2
- Dasatinib: Hold when ANC < 0.5 × 10⁹/L until recovery to ≥ 1.0 × 10⁹/L, then resume; for recurrence, reduce dose progressively 3
- Bosutinib and Ponatinib: Similar hold-and-resume protocols with dose reductions for recurrent neutropenia 3
Other targeted agents causing neutropenia include:
- Midostaurin, Quizartinib, Glasdegib: When combined with chemotherapy, cause febrile neutropenia requiring standard antimicrobial prophylaxis 4
- Venetoclax: Particularly when combined with azacitidine, requires dose interruptions between cycles and consideration of dose reduction or prophylactic G-CSF 4
- Rituximab: Can cause late-onset neutropenia (R-LON) occurring weeks to months after administration, which may resolve spontaneously but can cause severe infections in elderly or renally impaired patients 5
Antibiotics
Multiple antibiotic classes are implicated:
- Sulfamethoxazole-trimethoprim: Well-documented association with neutropenia 6
- β-lactam antibiotics: Recognized cause of drug-induced immune neutropenia 6
- Vancomycin: Associated with neutropenia 6
- Quinolones (ciprofloxacin, levofloxacin, moxifloxacin): Moxifloxacin specifically documented to cause rapid-onset neutropenia (within 2 days) that resolves within 4 days of discontinuation 7
Critical caveat: These same antibiotics are used for prophylaxis during chemotherapy-induced neutropenia 8, 9, 10, creating a clinical paradox where the prophylactic agent itself may contribute to neutropenia.
Antipsychotics
Clozapine is the most notorious psychiatric medication causing neutropenia, with current consensus recommending:
- ANC threshold for cessation lowered to 1.0 × 10⁹/L (0.5 × 10⁹/L for DARC/ACKR1-null individuals) 11
- Monitoring frequency reduced to every 4 weeks after 18 weeks, discontinued after 2 years 11
Anti-inflammatory Drugs
NSAIDs as a class carry a 4.2-fold increased risk of neutropenia (adjusted odds ratio), with no single NSAID showing unique risk 12. The association persists even excluding phenylbutazone and indomethacin (OR 3.5) 12. Specific agents documented include:
- Dipyrone
- Diclofenac
- Indomethacin 12
Mesalazine (5-aminosalicylate) rarely causes neutropenia, typically occurring years after initiation and resolving within 2 weeks of discontinuation 13
Other Medications
- Antithyroid drugs (propylthiouracil): Well-established cause 6
- Anticonvulsants (carbamazepine): Documented association 6
- Antiplatelet agents (ticlopidine): Known to cause neutropenia 6
- Levamisole: Associated with neutropenia 6
Mechanism and Clinical Approach
Drug-induced immune neutropenia (DIIN) occurs when drug-dependent antibodies form against neutrophil membrane glycoproteins, causing destruction 6. The incidence ranges from 1.6 to 15.4 cases per million population per year for nonchemotherapy drugs 6.
For a 64-year-old Black woman with persistent neutropenia, recognize that:
- Lower baseline neutrophil counts are physiologic in individuals of African descent (benign ethnic neutropenia)
- Medication review is essential, including over-the-counter NSAIDs
- Recent rituximab exposure (within 2-3 months) should raise suspicion for R-LON 5
- Elderly patients with renal impairment are at higher risk for severe infections from drug-induced neutropenia 5
Management priorities:
- Discontinue suspected offending agent
- Monitor for recovery (typically within 2-14 days for most drugs) 13, 7
- Consider G-CSF for severe neutropenia (ANC < 0.5 × 10⁹/L) with infection risk 6, 14
- Rule out alternative causes including clonal hematopoiesis or evolving myeloid malignancy if neutropenia persists despite drug discontinuation 14, 15